Internal Medicine Alert – October 15, 2018

October 15, 2018

• Revised Anticoagulation Therapy Guidelines for Atrial Fibrillation Patients

  More patients with atrial fibrillation may receive anticoagulation, according to new recommendations.

  Read more

• Are In-hospital Deaths Related to Community-acquired Pneumonia Preventable?

  This secondary analysis of data from five tertiary care centers found that among patients hospitalized for community-acquired pneumonia, very few deaths potentially were related to a lapse in in-hospital quality of pneumonia care.

  Read more

• Home-based Detection of Undiagnosed Atrial Fibrillation

  In patients with risk factors for atrial fibrillation, screening with a self-applied wearable ECG patch resulted in significantly increased rates of new atrial fibrillation diagnoses within four months, along with greater use of anticoagulants and healthcare resources.

  Read more

• Eravacycline Injection (Xerava)

  The FDA has approved a new parenteral, broad-spectrum antibiotic in the tetracycline class for the treatment of complicated intra-abdominal infections.

  Read more

• Biventricular Hypertrophy in an Asymptomatic Patient?

  Read more